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 In this issue of  Kidney International , 
 Castellarnau and colleagues 1 describe a 
method of machine monitoring of hemo-
dialysis adequacy based on analysis of 
ultraviolet (UV) absorbance of the out-
fl owing dialysate during the dialysis treat-
ment. From this information, the log 
blood urea nitrogen (BUN) slope can be 
determined. Th is slope is the ratio of clear-
ance ( K ) to urea distribution volume ( V ). 
By multiplying session length ( t ) and 
adjusting for fl uid removal, the ratio of 
cleared volume to body water ( Kt/V ) can 
be estimated. Th e concept of using dia-
lysate urea analysis 2 – 8 or UV absorbance 9 
to measure adequacy has been described 
previously ( Figure 1 ). 
 Certain dialyzable solutes, including 
uric acid, but not urea, absorb UV. 9,10 Th e 
UV absorbance in dialysate can be meas-
ured continuously without reagents and 
so is more suited for integration into a 
dialysis machine than existing urea 
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sensors. Th e data of Castellarnau  et al. 
suggest that UV absorbance is suffi  ciently 
representative of urea concentration that 
more specifi c measurement of urea may 
not be necessary. 1 UV-absorbing solutes 
are of higher molecular weight (that is, 
are more slowly dialyzed) than urea, so 
the method will underestimate urea clear-
ance. Because the UV method detects a 
range of solutes, it is theoretically suscep-
tible to interfering factors. Larger valida-
tion studies in diff erent groups of patients 
may be needed. 
 Th e advantage of this method is that 
 Kt / V is calculated directly from measure-
ments in dialysate, and values for absolute 
concentrations  K and  V are not required. 
A variety of diff erent approaches to esti-
mating urea removal have been proposed, 
including measurement of urea in recir-
culating dialysate, which will equilibrate 
with the concentration in blood. 2 
 A disadvantage is that changes in clear-
ance during dialysis due to membrane 
fouling or changing blood or dialysate 
fl ow will disturb the ratio between blood 
and dialysate concentrations. By integrat-
ing the sensor into the dialysis machine, 
the method of Castellarnau  et al. 1 has 
accounted for changes in fl ow and can 
include the eff ect of ultrafi ltration. By 
continuous analysis of the dialysate 
measurements over time, the post-dialy-
sis rebound may be predicted for calcula-
tion of an equilibrated  Kt / V . Th e method 
also claims to be capable of detecting 
membrane fouling by detecting unex-
pected changes in measurements over 
time, but this probably requires more 
validation. 
 Conductivity clearance measurement 
(CC) is a diff erent approach to machine-
monitored hemodialysis adequacy 
( Figure 2 ) that has been available in many 
regions of the world for several years 
now. 11 – 13 With CC, the dialysis machine 
briefl y and periodically increases and 
then reduces the infl owing dialysate con-
ductivity. Mass transfer and clearance can 
be calculated by analysis of the changes in 
conductivity at the dialysate infl ow and 
outfl ow pursuant to these alterations in 
dialysate electrolyte concentration. 11 – 13 
Because of time delays and the way in 
which this measurement is performed, 
CC estimates of dialyzer clearance also 
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include the eff ects of access recirculation 
if present, and of cardiopulmonary recir-
culation. 11 – 13 Unlike the dialysate con-
centration or UV methods, CC is not 
able to calculate  Kt / V from direct meas-
urement. CC can accurately measure  K 
and  t but requires separate measurement 
and input of the urea distribution vol-
ume  V in order to calculate  Kt / V . Th e 
latter can be obtained from a previous 
urea modeling session in which pre- and 
post-dialysis BUN values were meas-
ured, from bioimpedance, or from an 
anthropometric estimate of total body 
water. 14 Each of these methods for cal-
culating  V is indirect and prone to error. 
Conductivity clearance is not the same 
as urea clearance, though its nature and 
relationship to urea clearance are well 
understood. 
 How can machine monitoring of ade-
quacy be useful? Th ere are several advan-
tages to these techniques. 
 1. Elimination of pre- and post-dialysis 
blood urea nitrogen measurements 
 Dialysis adequacy is usually monitored 
with the use of monthly pre- and post-
dialysis blood samples. Th ese samples 
require signifi cant resources, including 
staff  time, disposables, logistics, informa-
tion management, and planning. Th e 
sampling may also confer infection risk 
to the patients and staff , especially if a 
needle is used. Th e post-dialysis sample 
is particularly troublesome, as it has to 
be paired with the pre-dialysis sample 
and to be taken at a busy time right at 
the end of dialysis and by a specific 
protocol to avoid interference from 
access recirculation. 15,16 
 With the UV method, assuming that 
validation studies confi rm that it reliably 
refl ects urea, there should no longer be 
any need to measure pre- or post-dialysis 
blood urea concentrations. As well as 
calculating  Kt / V , the dialysate UV meas-
urements could be used to deduce the 
urea mass removed, hence the protein 
catabolic rate (PCR). An accurate value 
for urea distribution volume ( V ), for 
example, using bioimpedance, is required 
for calculation of normalized protein 
catabolic rate (nPCR). 5 – 7 
 With CC, pre-dialysis BUN values 
would still be required, because a BUN 
value is necessary for the estimation of 
protein catabolic rate. If  V can be meas-
ured reliably (for example, by bioimped-
ance), then the troublesome post-dialysis 
sample can be avoided. Without a reliable 
measurement of  V , pre- and post-dialysis 
BUN measurements are still needed to 
compute  V but could be performed at a 
reduced frequency (for example, three to 
six monthly). 
 2. Ensuring that the patient receives the 
prescribed dose of dialysis each time 
 Traditional adequacy methods using pre- 
and post-dialysis blood samples are typi-
cally performed monthly under controlled 
conditions and may not accurately refl ect 
a typical dialysis. Th ere may be a delay of 
more than a month before an inadequate 
dialysis is detected and confi rmed. With 
machine-monitored adequacy methods, 
there is continuous feedback to patients 
and staff  regarding the adequacy of each 
session. Th e eff ects of changes in prescrip-
tion (for example, reduction of blood fl ow 
or time) are immediately apparent. Where 
 K is unavoidably reduced (for example, by 
access problems), the dialysis can be pro-
longed until the minimum  Kt / V target 
is delivered. 
 3. More accurate delivery of a dialysis 
prescription to new patients 
 One challenge in providing dialysis to 
incident patients is that patient urea dis-
tribution volume is completely unknown 
and may diff er markedly from anthropo-
metric estimates.  K may also be diffi  cult 
to predict with new vascular access. With 
dialysate urea or UV monitoring, the 
delivered  Kt / V is displayed as the dialysis 
progresses, and values for  K and  V are not 
needed. With CC, a value for  V is still 
 Figure 1  |  Schematic showing typical locations for an outflowing dialysate urea monitor or 
ultraviolet absorbance monitor . 
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 Figure 2  |  In the conductivity clearance method, the schematic shows typical locations for 
conductivity monitors of the inflowing and outflowing dialysate . (The monitors actually are 
located within the dialysis machine housing.) The conductivity clearance method requires that the 
machine periodically alter the proportioning of dialysate concentrate with inlet water to change 
the inflowing dialysate conductivity in a predictable manner. 
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required, but this can be measured at a 
convenient time before dialysis (for 
example, by bioimpedance). 
 4. Detection of access recirculation 
 With traditional adequacy methods based 
on blood samples, access recirculation 
(AR) is suspected when the urea reduc-
tion ratio decreases for no apparent reason 
in comparison with previous modeled 
sessions. A more accurate method, taking 
other factors that may reduce  K into 
account, is to follow changes in  V calcu-
lated by a urea kinetic model. Th e model 
eff ectively calculates  Kt / V directly from 
pre- and post-dialysis BUN. Th e actual 
treatment time ( t ) and a  ‘ theoretical ’ value 
of  K , calculated from dialyzer overall mass 
transfer coeffi  cient ( KoA ) and blood and 
dialysate fl ow rate, are then used to calcu-
late  V . Since the model has no knowledge 
of the actual  K , any unexpected fall in 
measured  Kt / V (for example, due to AR) 
is interpreted by the model as an increase 
in  V . Unexpected increases in calculated 
 V are likely to be caused by AR, especially 
if  V calculated by the model is signifi-
cantly higher than that calculated from 
anthropometric data. 
 With dialysate urea or UV methods, 
the presence of AR could be deduced by 
analy sis of the way the measurement 
changes at the start of dialysis. AR causes 
an abnormally precipitous fall in dialysate 
urea concentration (and, presumably, UV 
absorption, though this has not been 
described in the literature) at the start of 
dialysis. With CC, actual clearance will be 
lower than the  ‘ theoretical ’ clearance when 
there is AR. AR may be caused by incorrect 
needle position (for example, arterial nee-
dle downstream of the venous needle). Th is 
AR could be intermittent, dependent on 
needling position, and be missed by 
monthly adequacy measurements. With 
machine-monitored methods, AR would 
be detected immediately each time 
it occurs. 
 5. Performing quality assurance of 
reprocessed dialyzers 
 Reused dialyzers are prone to fi ber block-
age or membrane fouling, which may 
reduce clearance. Th is should be detected 
and accounted for. When the clearance 
falls below acceptable levels, the dialyzer 
is discarded. Measurements of fi ber bun-
dle volume are used as an indirect method 
to detect reductions in dialyzer perform-
ance. Monthly adequacy assessment is far 
too infrequent to reliably detect dialyzer 
ineffi  ciency, as this can occur suddenly. 
With machine-monitored methods, dia-
lyzer performance is monitored each 
treatment in a more direct way and prob-
ably more accurately than by fi ber bundle 
volume. 
 In conclusion, machine monitoring of 
hemodialysis adequacy using UV, dialysate 
urea, or CC methods should translate into 
substantial benefi ts to patient care and, 
depending on acquisition and maintenance 
costs, may also result in considerable cost 
savings. Conductivity clearance is a well-
validated method for assessing dialysis 
adequacy but does not completely remove 
the need for BUN measurement. UV has 
potential advantages over conductivity 
clearance (including the ability to avoid 
input of  V , and omit BUN measurement 
altogether) but needs more validation 
study. Actually, both dialysate urea analysis 
and CC can be combined to obtain reliable 
estimates of both pre- and post-dialysis 
BUN 8 in addition to the standard measures 
of dialysis adequacy. 
 Given that guidelines lag behind pub-
lished literature, and that government-
mandated quality assurance measures lag 
behind guidelines, it is important that 
early adopters of these new technologies 
undertake, and publish as rapidly as pos-
sible, quality assurance studies compar-
ing use of machine-monitored adequacy 
with pre- and post-dialysis BUN 
approaches, focusing on monitoring of 
changes in  Kt / V , nPCR, AR, and per-
formance of reused dialyzers. Current 
Kidney Disease Outcomes Quality Ini-
tiative 15 guidelines mandate that ade-
quacy be assessed at least monthly, by 
pre- and post-dialysis blood samples. Th e 
European Best Practice Guidelines allow 
for the use of alternative methods of 
adequacy assessment such as online 
clearance, as long as the method has been 
validated and referenced to urea kinetic 
modeling, but no specific alternative 
method is endorsed. 16 One would antic-
ipate that the next iteration of dialysis 
adequacy guidelines will be able to 
endorse the use of machine monitoring 
of adequacy as an alternative to the older 
BUN-based techniques. 
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